TLR3 and common variable immunodeficiency: In addition, both Th22/Tc22 from CVID patients had an increased response to TLR7/8/CL097 agonists as well as to SEB (Fig. 3b); however, Th22 cells were decreased in CVID compared to HC subjects upon TLR3 activation.